Peptic ulcer disease;Úlcera péptica

Medicine

Volumn 11, Issue 3, 2012, Pages 137-141

  Ber Nieto, Y ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Clinical manifestations; Diagnosis; Helicobacter pylori; NSAID; Peptic ulcer; Treatment

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; DRUG USE; ERADICATION THERAPY; GASTROINTESTINAL MUCOSA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INGESTION; PEPTIC ULCER;

EID: 84857712951     PISSN: 03045412     EISSN: 15788822     Source Type: Journal    
DOI: 10.1016/S0304-5412(12)70275-5     Document Type: Article

References (18)

1. H.R. Mertz, W.L. Peterson, and J.H. Walsh "Familial hyperpepsinogenemia" and Helicobacter pylori infection Am J Gastroentorol 95 2000 943 946 (Pubitemid 30196729)
2. A. Sonnenberg, S.A. Müller-Lissner, E. Vogel, P. Schmid, J.J. Gonvers, and P. Peter Predictors of duodenal ulcer healing and relapse Gastroenterology 81 1981 1061 1067 (Pubitemid 11029685)
3. B.J. Marshall Helicobacter pylori Am J Gastroenterol 89 1994 S116 S128
4. M.J. Blaser Not all Helicobacter pylori strains are created equal. Should all be eliminated? Lancet 349 1997 1020 1022 (Pubitemid 27149816)
5. L. Laine, R.J. Hopkins, and L.S. Girardi Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials Am J Gastroenterol 93 1998 1409 1415 (Pubitemid 29075174)
6. L. Laine Approaches to nonsteroidal anti-inflammatory drug use in the high risk patient Gastroentorology 120 2001 594 606 (Pubitemid 32171634)
7. G. Singh, and G. Triadafilopoulos Epidemiology of NSAID induced gastrointestinal complications J Rheumatol 26 1999 18 24 (Pubitemid 29183022)
8. J.Q. Huang, S. Sridhar, and R.H. Hunt Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis Lancet 359 2001 14 22
9. F.K. Chan, J.J. Sung, S.C. Chung, K.F. To, M.Y. Yung, and V.K. Leung Randomised trial of eradication of Helicobacter pylori before starting non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers Lancet 350 1997 975 979 (Pubitemid 27421105)
10. F.K. Chan, K.F. To, J.C. Wu, M.Y. Yung, W.K. Leung, and T. Kwok Eradication of Helicobacter pylori and risk of peptic ulcers in patient starting long-term treatment with non-steroidal anti-inflammatory drugs; A randomised trial Lancet 359 2002 9 13 (Pubitemid 34119189)
11. R. Pounder Silent peptic ulceration. Deadly silence or golden silence Gastroentoloroly 96 1989 626 631 (Pubitemid 19038538)
12. M.S. Levine Role of the double contrast upper gastrointestinal series in the 1990s Gastroenterol Clin North Am 24 1995 289 308
13. D.Y. Graham, J.T. Schwartz, G.D. Cain, and F. Gyorkey Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma Gastroentology 82 1982 228 231 (Pubitemid 12213633)
14. P. Bytzer Endoscopic follow-up study of gastric ulcer to detect malignancy: Is it worthwhile? Scand J Gastroenterol 26 1991 1193 1199
15. P.N. Maton Omeprazole N Engl J Me 324 1991 965 975
16. T. Poynard, M. Lemaire, and H. Agostini Meta-analysis of radomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer Eur J Gastroenterol Hepatol 7 1995 661 665
17. M. Martí-Cabrera, M. Martí-Masanet, and J.V. Esplugues ¿Es real el riesgo de osteroporosis y riesgo de fractura con el uso crónico de inhibidores de la bomba de protones? Gastroenterol Hepatol 34 2011 271 277
18. L. Laine, R.J. Hopkins, and L.S. Girardi Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated?. A meta-analysis of rigorously designed trials Am J Gastroenterol 93 1998 1409 1415 (Pubitemid 29075174)